  | Ozkan, J., & Neyses, L. (01 October 2017). A physician who has crossed many frontiers and has changed direction a number of times . European Heart Journal, 38 (37), 2799–2800. |
 | Kurusamy, S., López-Maderuelo, D., Little, R., Cadagan, D., Savage, A. M., Ihugba, J. C., Baggott, R. R., Rowther, F. B., Martínez-Martínez, S., Gómez-del Arco, P., Murcott, C., Wang, W., Nistal, J. F., Oceandy, D., Neyses, L., Wilkinson, R. N., Cartwright, E. J., Redondo, J. M., & Armesilla, A. L. (2017). Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion. Journal of Molecular and Cellular Cardiology, (109), 38-47. doi:10.1016/j.yjmcc.2017.07.001  Peer reviewed |
 | Stafford, N., Wilson, C., Oceandy, D., Neyses, L., & Cartwright, E. J. (2017). The Plasma Membrane Calcium ATPases and Their Role as Major New Players in Human Disease. Physiological Reviews, 97 (3), 1089-1125. doi:10.1152/physrev.00028.2016 Peer Reviewed verified by ORBi |
 | Neyses, L., Mohamed, T., Abou-Leisa, R., Stafford, N., Maqsood, A., Zi, M., Prehar, S., Baudoin-Stanley, F., Wang, X., Cartwright, E., & Oceandy, D. (2016). The Plasma Membrane Calcium ATPase 4 Signaling in Cardiac Fibroblasts Mediates Cardiomyocyte Hypertrophy. Nature Communications. doi:10.1038/ncomms11074 Peer Reviewed verified by ORBi |
 | Kristensen, S. L., Preiss, D., Jhund, P. S., Squire, I., Cardoso, J. S., Merkely, B., Martinez, F., Starling, R. C., Desai, A. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J. V., Packer, M., & Neyses, L. (Other coll.). (2016). Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial. Circulation: Heart Failure, 9 (1). doi:10.1161/CIRCHEARTFAILURE.115.002560 Peer Reviewed verified by ORBi |
 | Ritchie, J., Green, D., Chrysochou, T., Hegarty, J., Handley, K., Ives, N., Wheatley, K., Houston, G., Wright, J., Neyses, L., Chalmers, N., Mark, P., Patel, R., Moss, J., Roditi, G., Eadington, D., Lukaschuk, E., Cleland, J., & Kalra, P. A. (2016). Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrology Dialysis Transplantation. doi:10.1093/ndt/gfw107 Peer Reviewed verified by ORBi |
 | Little, R., Cartwright, E. J., Neyses, L., & Austin, C. (2016). Plasma membrane calcium ATPases (PMCAs) as potential targets for the treatment of essential hypertension. Pharmacology and Therapeutics, 159, 23-34. doi:10.1016/j.pharmthera.2016.01.013 Peer Reviewed verified by ORBi |
 | Ryan, Z. C., Craig, T. A., Filoteo, A. G., Westendorf, J. J., Cartwright, E. J., Neyses, L., Strehler, E. E., & Kumar, R. (2015). Deletion of the intestinal plasma membrane calcium pump, isoform 1, Atp2b1, in mice is associated with decreased bone mineral density and impaired responsiveness to 1, 25-dihydroxyvitamin D3. Biochemical and Biophysical Research Communications, 467 (1), 152-6. doi:10.1016/j.bbrc.2015.09.087 Peer reviewed |
 | Packer, M., McMurray, J. J. V., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M., Andersen, K., Arango, J. L., Arnold, J. M., Belohlavek, J., Bohm, M., Boytsov, S., Burgess, L. J., Cabrera, W., ... Neyses, L. (Other coll.). (2015). Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation, 131 (1), 54-61. doi:10.1161/CIRCULATIONAHA.114.013748 Peer Reviewed verified by ORBi |
 | Mohamed, T. M. A., Zi, M., Prehar, S., Maqsood, A., Abou-Leisa, R., Nguyen, L., Pfeifer, G. P., Cartwright, E. J., Neyses, L., & Oceandy, D. (2014). The tumour suppressor Ras-association domain family protein 1A (RASSF1A) regulates TNF-alpha signalling in cardiomyocytes. Cardiovascular Research, 103 (1), 47-59. doi:10.1093/cvr/cvu111 Peer Reviewed verified by ORBi |
 | Baggott, R. R., Alfranca, A., Lopez-Maderuelo, D., Mohamed, T. M. A., Escolano, A., Oller, J., Ornes, B. C., Kurusamy, S., Rowther, F. B., Brown, J. E., Oceandy, D., Cartwright, E. J., Wang, W., Gomez-del Arco, P., Martinez-Martinez, S., Neyses, L., Redondo, J. M., & Armesilla, A. L. (2014). Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin. Arteriosclerosis, Thrombosis and Vascular Biology, 34 (10), 2310-20. doi:10.1161/ATVBAHA.114.304363 Peer Reviewed verified by ORBi |
 | McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., & Neyses, L. (Other coll.). (2014). Angiotensin-neprilysin inhibition versus enalapril in heart failure. The New England journal of medicine, 371 (11), 993-1004. doi:10.1056/NEJMoa1409077 Peer reviewed |
 | Zi, M., Maqsood, A., Prehar, S., Mohamed, T. M. A., Abou-Leisa, R., Robertson, A., Cartwright, E. J., Ray, S. G., Oh, S., Lim, D.-S., Neyses, L., & Oceandy, D. (2014). The mammalian Ste20-like kinase 2 (Mst2) modulates stress-induced cardiac hypertrophy. The Journal of biological chemistry, 289 (35), 24275-88. doi:10.1074/jbc.M114.562405 Peer reviewed |
 | Mamas, M. A., Anderson, S. G., Ratib, K., Routledge, H., Neyses, L., Fraser, D. G., Buchan, I., de Belder, M. A., Ludman, P., & Nolan, J. (2014). Arterial access site utilization in cardiogenic shock in the United Kingdom: is radial access feasible? American Heart Journal, 167 (6), 900-8.e1. doi:10.1016/j.ahj.2014.03.007 Peer Reviewed verified by ORBi |
 | Fath-Ordoubadi, F. A., Spaepen, E. B., El-Omar, M. A., Fraser, D. G. A., Khan, M. A. A., Neyses, L., Danzi, G. B. C., Roguin, A. D., Paunovic, D. E., & Mamas, M. A. A. F. (2014). Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study. PLoS ONE, 9 (2). doi:10.1371/journal.pone.0088577 Peer Reviewed verified by ORBi |
 | Ryden, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H.-P., Huikuri, H., Marre, M., Marx, N., Mellbin, L., Ostergren, J., Patrono, C., Seferovic, P., Uva, M. S., Taskinen, M.-R., Tendera, M., ... Neyses, L. (Other coll.). (2014). ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Diabetes and Vascular Disease Research, 11 (3), 133-73. doi:10.1177/1479164114525548 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Fraser, D. G., Ratib, K., Fath-Ordoubadi, F., El-Omar, M., Nolan, J., & Neyses, L. (2014). Minimising radial injury: Prevention is better than cure. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 10 (7), 824-832. doi:10.4244/EIJV10I7A142 Peer reviewed |
Khan, M. A., Deaton, C., Rutter, M. K., Neyses, L., & Mamas, M. A. (March 2013). Incretins as a novel therapeutic strategy in patients with diabetes and heart failure. Heart Failure Reviews, 18 (2), 141-8. doi:10.1007/s10741-012-9318-y Peer Reviewed verified by ORBi |
 | Egom, E. E., Rose, R. A., Neyses, L., Soran, H., Cleland, J. G. F., & Mamas, M. A. (2013). Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy. Critical Reviews in Clinical Laboratory Sciences, 50 (3), 79-89. doi:10.3109/10408363.2013.813013 Peer Reviewed verified by ORBi |
  | Ryden, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H.-P., Huikuri, H., Marre, M., Marx, N., Mellbin, L., Ostergren, J., Patrono, C., Seferovic, P., Uva, M. S., Taskinen, M.-R., Tendera, M., ... Xuereb, R. G. (2013). ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). European Heart Journal, 34 (39), 3035-87. doi:10.1093/eurheartj/eht108 Peer Reviewed verified by ORBi |
 | Khan, M. A., Ahmed, F., Neyses, L., & Mamas, M. A. (2013). Atrial fibrillation in heart failure: The sword of Damocles revisited. World Journal of Cardiology, 5 (7), 215-27. doi:10.4330/wjc.v5.i7.215 Peer Reviewed verified by ORBi |
 | Egom, E. E., Mamas, M. A., Chacko, S., Stringer, S. E., Charlton-Menys, V., El-Omar, M., Chirico, D., Clarke, B., Neyses, L., Cruickshank, J. K., Lei, M., & Fath-Ordoubadi, F. (2013). Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury. Frontiers in Physiology, 4, 130. doi:10.3389/fphys.2013.00130 Peer Reviewed verified by ORBi |
 | Liu, W., Zi, M., Tsui, H., Chowdhury, S. K., Zeef, L., Meng, Q.-J., Travis, M., Prehar, S., Berry, A., Hanley, N. A., Neyses, L., Xiao, R.-P., Oceandy, D., Ke, Y., Solaro, R. J., Cartwright, E. J., Lei, M., & Wang, X. (2013). A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin. Circulation: Heart Failure, 6 (4), 833-44. doi:10.1161/CIRCHEARTFAILURE.112.000123 Peer Reviewed verified by ORBi |
 | Fiuzat, M., O'Connor, C. M., Gueyffier, F., Mascette, A. M., Geller, N. L., Mebazaa, A., Voors, A. A., Adams, K. F., Pina, I. L., Neyses, L., Muntendam, P., Felker, G. M., Pitt, B., Zannad, F., & Bristow, M. R. (2013). Biomarker-guided therapies in heart failure: a forum for unified strategies. Journal of Cardiac Failure, 19 (8), 592-9. doi:10.1016/j.cardfail.2013.05.012 Peer Reviewed verified by ORBi |
 | Mohamed, T. M. A., Abou-Leisa, R., Baudoin, F., Stafford, N., Neyses, L., Cartwright, E. J., & Oceandy, D. (2013). Development and characterization of a novel fluorescent indicator protein PMCA4-GCaMP2 in cardiomyocytes. Journal of Molecular and Cellular Cardiology, 63, 57-68. doi:10.1016/j.yjmcc.2013.07.007 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Ratib, K., Routledge, H., Neyses, L., Fraser, D. G., de Belder, M., Ludman, P. F., & Nolan, J. (2013). Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice? JACC. Cardiovascular Interventions, 6 (7), 698-706. doi:10.1016/j.jcin.2013.03.011 Peer Reviewed verified by ORBi |
 | Ahmed, F. Z., Khattar, R. S., Zaidi, A. M., Neyses, L., Oceandy, D., & Mamas, M. (2013). Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases. Heart Failure Reviews. doi:10.1007/s10741-013-9390-y Peer Reviewed verified by ORBi |
 | Mohamed, T. M. A., Zakeri, S. A., Baudoin, F., Wolf, M., Oceandy, D., Cartwright, E. J., Gul, S., & Neyses, L. (2013). Optimisation and validation of a high throughput screening compatible assay to identify inhibitors of the plasma membrane calcium ATPase pump--a novel therapeutic target for contraception and malaria. Journal of Pharmacy and Pharmaceutical Sciences, 16 (2), 217-30. doi:10.18433/j3pg68 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Ratib, K., Routledge, H., Fath-Ordoubadi, F., Neyses, L., Louvard, Y., Fraser, D. G., & Nolan, J. (06 December 2012). Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart, 98 (4), 303-11. doi:10.1136/heartjnl-2011-300558 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Farooq, V., Latib, A., Sastry, S., D'Souza, S., Williams, P., Wiper, A., Neyses, L., El-Omar, M., Fraser, D. G., & Fath-Ordoubadi, F. (2012). Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world experience. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 7 (10), 1170-80. doi:10.4244/EIJV7I10A188 Peer Reviewed verified by ORBi |
 | Neyses, L. (2012). Cardiac metabolism; from bench to bedside: Diabetic cardiomyopathy, a disease of cardiac metabolism? In J. D. Schilling & D. L. Mann (Eds.), Diabetic cardiomyopathy: bench to bedside. London, United Kingdom: Royal Society of Medicine Press Ltd. doi:10.1016/j.hfc.2012.06.007 Peer reviewed |
 | Prendergast, B., Coope, L. T., Crijns, H., Falkenstein, E., Folsch, U., Halvorsen, S., Janssens, S., Jokinen, E., Kroemer, H. K., Lucke, A., Murer, H., Nagel, E., Neyses, L., Perk, J., Probst-Hensch, N., Rietschel, E. T., Rutten, H., Steingen, C., Tedgui, A., ... Kristensen, S. D. (2012). The German Centre for Cardiovascular Research. European Heart Journal, 33 (9), 1033-36,1036. doi:10.1093/eurheartj/ehs093 Peer Reviewed verified by ORBi |
 | Mega, J. L., Braunwald, E., Wiviott, S. D., Bassand, J.-P., Bhatt, D. L., Bode, C., Burton, P., Cohen, M., Cook-Bruns, N., Fox, K. A. A., Goto, S., Murphy, S. A., Plotnikov, A. N., Schneider, D., Sun, X., Verheugt, F. W. A., Gibson, C. M., & Neyses, L. (Other coll.). (2012). Rivaroxaban in patients with a recent acute coronary syndrome. The New England journal of medicine, 366 (1), 9-19. doi:10.1056/NEJMoa1112277 Peer reviewed |
 | Hegab, Z., Gibbons, S., Neyses, L., & Mamas, M. A. (2012). Role of advanced glycation end products in cardiovascular disease. World Journal of Cardiology, 4 (4), 90-102. doi:10.4330/wjc.v4.i4.90 Peer Reviewed verified by ORBi |
 | Baggott, R. R., Mohamed, T. M. A., Oceandy, D., Holton, M., Blanc, M. C., Roux-Soro, S. C., Brown, S., Brown, J. E., Cartwright, E. J., Wang, W., Neyses, L., & Armesilla, A. L. (2012). Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells. Carcinogenesis, 33 (12), 2362-8. doi:10.1093/carcin/bgs282 Peer Reviewed verified by ORBi |
 | Tierney, S., Mamas, M., Woods, S., Rutter, M. K., Gibson, M., Neyses, L., & Deaton, C. (2012). What strategies are effective for exercise adherence in heart failure? A systematic review of controlled studies. Heart Failure Reviews, 17 (1), 107-15. doi:10.1007/s10741-011-9252-4 Peer Reviewed verified by ORBi |
 | Khan, M. A., Neyses, L., & Mamas, M. A. (2012). Atrial fibrillation in heart failure: an innocent bystander? Current Cardiology Reviews, 8 (4), 273-80. doi:10.2174/157340312803760839 Peer Reviewed verified by ORBi |
 | Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., Huber, K., Ohman, M., Petrie, M. C., Sonntag, F., Uva, M. S., Storey, R. F., Wijns, W., Zahger, D., & Neyses, L. (Other coll.). (2011). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 32 (23), 2999-3054. doi:10.1093/eurheartj/ehr236 Peer Reviewed verified by ORBi |
 | Appleby, C. E., Khattar, R. S., Morgan, K., Clarke, B., Curzen, N., Neyses, L., & Fath-Ordoubadi, F. (2011). Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 6 (6), 748-53. doi:10.4244/EIJV6I6A127 Peer Reviewed verified by ORBi |
 | Nair, S., Fath-Ordoubadi, F., Clarke, B., El-Omar, M., Foley, J., Fraser, D. G., Mahadevan, V. S., Neyses, L., Khattar, R. S., & Mamas, M. A. (2011). Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 6 (8), 985-91. doi:10.4244/EIJV6I8A170 Peer Reviewed verified by ORBi |
 | Dunn, W. B., Goodacre, R., Neyses, L., & Mamas, M. (2011). Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook. Bioanalysis, 3 (19), 2205-22. doi:10.4155/bio.11.223 Peer Reviewed verified by ORBi |
 | Brown, M., Wedge, D. C., Goodacre, R., Kell, D. B., Baker, P. N., Kenny, L. C., Mamas, M. A., Neyses, L., & Dunn, W. B. (2011). Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets. Bioinformatics, 27 (8), 1108-12. doi:10.1093/bioinformatics/btr079 Peer reviewed |
 | Cartwright, E. J., Oceandy, D., Austin, C., & Neyses, L. (2011). Ca2+ signalling in cardiovascular disease: the role of the plasma membrane calcium pumps. Science China Life Sciences, 54 (8), 691-8. doi:10.1007/s11427-011-4199-1 Peer Reviewed verified by ORBi |
 | Liu, W., Zi, M., Naumann, R., Ulm, S., Jin, J., Taglieri, D. M., Prehar, S., Gui, J., Tsui, H., Xiao, R.-P., Neyses, L., Solaro, R. J., Ke, Y., Cartwright, E. J., Lei, M., & Wang, X. (2011). Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation, 124 (24), 2702-15. doi:10.1161/CIRCULATIONAHA.111.048785 Peer Reviewed verified by ORBi |
 | Tierney, S., Elwers, H., Sange, C., Mamas, M., Rutter, M. K., Gibson, M., Neyses, L., & Deaton, C. (2011). What influences physical activity in people with heart failure?: a qualitative study. International Journal of Nursing Studies, 48 (10), 1234-43. doi:10.1016/j.ijnurstu.2011.03.003 Peer Reviewed verified by ORBi |
 | Cartwright, E. J., Mohamed, T., Oceandy, D., & Neyses, L. (2011). Calcium signaling dysfunction in heart disease. BioFactors (Oxford, England), 37 (3), 175-81. doi:10.1002/biof.149 Peer reviewed |
 | Mamas, M., Dunn, W. B., Neyses, L., & Goodacre, R. (2011). The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Archives of Toxicology, 85 (1), 5-17. doi:10.1007/s00204-010-0609-6 Peer Reviewed verified by ORBi |
 | Mohamed, T. M. A., Oceandy, D., Zi, M., Prehar, S., Alatwi, N., Wang, Y., Shaheen, M. A., Abou-Leisa, R., Schelcher, C., Hegab, Z., Baudoin, F., Emerson, M., Mamas, M., Di Benedetto, G., Zaccolo, M., Lei, M., Cartwright, E. J., & Neyses, L. (2011). Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain. The Journal of biological chemistry, 286 (48), 41520-9. doi:10.1074/jbc.M111.290411 Peer reviewed |
 | Cleland, J. G. F., Teerlink, J. R., Senior, R., Nifontov, E. M., Mc Murray, J. J. V., Lang, C. C., Tsyrlin, V. A., Greenberg, B. H., Mayet, J., Francis, D. P., Shaburishvili, T., Monaghan, M., Saltzberg, M., Neyses, L., Wasserman, S. M., Lee, J. H., Saikali, K. G., Clarke, C. P., Goldman, J. H., ... Malik, F. I. (2011). The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. The Lancet, 378 (9792), 676-83. doi:10.1016/S0140-6736(11)61126-4 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Foley, J., Nair, S., Wiper, A., Clarke, B., El-Omar, M., Fraser, D. G., Khattar, R., Neyses, L., & Fath-Ordoubadi, F. (2011). A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis. Journal of Interventional Cardiology, 24 (2), 172-80. doi:10.1111/j.1540-8183.2010.00620.x Peer Reviewed verified by ORBi |
 | Zi, M., Kimura, T. E., Liu, W., Jin, J., Higham, J., Kharche, S., Hao, G., Shi, Y., Shen, W., Prehar, S., Mironov, A., Neyses, L., Bierhuizen, M. F. A., Boyett, M. R., Zhang, H., Lei, M., Cartwright, E. J., & Wang, X. (2011). Mitogen-activated protein kinase kinase 4 deficiency in cardiomyocytes causes connexin 43 reduction and couples hypertrophic signals to ventricular arrhythmogenesis. The Journal of biological chemistry, 286 (20), 17821-30. doi:10.1074/jbc.M111.228791 Peer reviewed |
 | Oceandy, D., Mohamed, T. M. A., Cartwright, E. J., & Neyses, L. (2011). Local signals with global impacts and clinical implications: lessons from the plasma membrane calcium pump (PMCA4). Biochimica et biophysica acta, 1813 (5), 974-8. doi:10.1016/j.bbamcr.2010.12.007 Peer reviewed |
 | Tierney, S., Mamas, M., Skelton, D., Woods, S., Rutter, M. K., Gibson, M., Neyses, L., & Deaton, C. (2011). What can we learn from patients with heart failure about exercise adherence? A systematic review of qualitative papers. Health Psychology, 30 (4), 401-10. doi:10.1037/a0022848 Peer Reviewed verified by ORBi |
 | Liu, W., Zi, M., Chi, H., Jin, J., Prehar, S., Neyses, L., Cartwright, E. J., Flavell, R. A., Davis, R. J., & Wang, X. (2011). Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload. Journal of Molecular and Cellular Cardiology, 50 (4), 702-11. doi:10.1016/j.yjmcc.2011.01.013 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Horner, S., Welch, E., Ashworth, A., Millington, S., Fraser, D., Fath-Ordoubadi, F., Neyses, L., & El-Omar, M. (2010). Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve. The Journal of invasive cardiology, 22 (6), 260-5. Peer reviewed |
 | Kimura, T. E., Jin, J., Zi, M., Prehar, S., Liu, W., Oceandy, D., Abe, J.-I., Neyses, L., Weston, A. H., Cartwright, E. J., & Wang, X. (2010). Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart. Circulation Research, 106 (5), 961-70. doi:10.1161/CIRCRESAHA.109.209320 Peer Reviewed verified by ORBi |
 | Holton, M. L., Wang, W., Emerson, M., Neyses, L., & Armesilla, A. L. (2010). Plasma membrane calcium ATPase proteins as novel regulators of signal transduction pathways. World Journal of Biological Chemistry, 1 (6), 201-8. doi:10.4331/wjbc.v1.i6.201 Peer Reviewed verified by ORBi |
 | Holton, M., Mohamed, T. M. A., Oceandy, D., Wang, W., Lamas, S., Emerson, M., Neyses, L., & Armesilla, A. L. (2010). Endothelial nitric oxide synthase activity is inhibited by the plasma membrane calcium ATPase in human endothelial cells. Cardiovascular Research, 87 (3), 440-8. doi:10.1093/cvr/cvq077 Peer Reviewed verified by ORBi |
 | Caldwell, J. C., Mamas, M. A., Neyses, L., & Garratt, C. J. (2010). What are the thromboembolic risks of heart failure combined with chronic or paroxysmal AF? Journal of Cardiac Failure, 16 (4), 340-7. doi:10.1016/j.cardfail.2009.12.004 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Deaton, C., Rutter, M. K., Yuille, M., Williams, S. G., Ray, S. G., New, J., Gibson, J. M., & Neyses, L. (2010). Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated? Journal of Cardiac Failure, 16 (9), 761-8. doi:10.1016/j.cardfail.2010.05.027 Peer Reviewed verified by ORBi |
 | Mamas, M., D'Souza, S., Hendry, C., Ali, R., Iles-Smith, H., Palmer, K., El-Omar, M., Fath-Ordoubadi, F., Neyses, L., & Fraser, D. G. (2010). Use of the sheathless guide catheter during routine transradial percutaneous coronary intervention: a feasibility study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 75 (4), 596-602. doi:10.1002/ccd.22246 Peer reviewed |
 | Cartwright, E. J., & Neyses, L. (2010). Evaluation of plasma membrane calcium/calmodulin-dependent ATPase isoform 4 as a potential target for fertility control. Handbook of Experimental Pharmacology, (198), 79-95. doi:10.1007/978-3-642-02062-9_6 Peer Reviewed verified by ORBi |
 | Gupta, S., Waywell, C., Gandhi, N., Clayton, N., Keevil, B., Clark, A. L., Ng, L. L., Brooks, N., & Neyses, L. (2010). The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction. European Journal of Heart Failure, 12 (7), 746-52. doi:10.1093/eurjhf/hfq090 Peer Reviewed verified by ORBi |
 | Neyses, L., & Mamas, M. (2010). Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomized controlled trials. Student BMJ, (18). Peer reviewed |
 | Mamas, M. A., Neyses, L., & Fath-Ordoubadi, F. (2010). A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction. Experimental and Clinical Cardiology, 15 (2), 20-4. Peer Reviewed verified by ORBi |
 | Mohamed, T. M. A., Baudoin-Stanley, F. M., Abou-Leisa, R., Cartwright, E., Neyses, L., & Oceandy, D. (2010). Measurement of plasma membrane calcium-calmodulin-dependent ATPase (PMCA) activity. Methods in Molecular Biology, 637, 333-42. doi:10.1007/978-1-60761-700-6_18 Peer Reviewed verified by ORBi |
 | Jones, S., Solomon, A., Sanz-Rosa, D., Moore, C., Holbrook, L., Cartwright, E. J., Neyses, L., & Emerson, M. (2010). The plasma membrane calcium ATPase modulates calcium homeostasis, intracellular signaling events and function in platelets. Journal of Thrombosis and Haemostasis, 8 (12), 2766-74. doi:10.1111/j.1538-7836.2010.04076.x Peer Reviewed verified by ORBi |
 | Mamas, M. A., Eichhofer, J., Hendry, C., El-Omar, M., Clarke, B., Neyses, L., Fath-Ordoubadi, F., & Fraser, D. (2009). Use of the Heartrail II catheter as a distal stent delivery device; an extended case series. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 5 (2), 265-71. doi:10.4244/EIJV5I2A41 Peer Reviewed verified by ORBi |
 | Liu, W., Zi, M., Jin, J., Prehar, S., Oceandy, D., Kimura, T. E., Lei, M., Neyses, L., Weston, A. H., Cartwright, E. J., & Wang, X. (2009). Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth. Circulation Research, 104 (7), 905-14. doi:10.1161/CIRCRESAHA.108.188292 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Caldwell, J. C., Chacko, S., Garratt, C. J., Fath-Ordoubadi, F., & Neyses, L. (2009). A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. European journal of heart failure, 11 (7), 676-83. doi:10.1093/eurjhf/hfp085 Peer reviewed |
 | Oceandy, D., Cartwright, E. J., & Neyses, L. (2009). Ras-association domain family member 1A (RASSF1A)-where the heart and cancer meet. Trends in Cardiovascular Medicine, 19 (8), 262-7. doi:10.1016/j.tcm.2010.02.008 Peer Reviewed verified by ORBi |
 | Oceandy, D., Pickard, A., Prehar, S., Zi, M., Mohamed, T. M. A., Stanley, P. J., Baudoin-Stanley, F., Nadif, R., Tommasi, S., Pfeifer, G. P., Armesilla, A. L., Cartwright, E. J., & Neyses, L. (2009). Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy. Circulation, 120 (7), 607-16. doi:10.1161/CIRCULATIONAHA.109.868554 Peer Reviewed verified by ORBi |
 | Mohamed, T. M. A., Oceandy, D., Prehar, S., Alatwi, N., Hegab, Z., Baudoin, F. M., Pickard, A., Zaki, A. O., Nadif, R., Cartwright, E. J., & Neyses, L. (2009). Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium. The Journal of biological chemistry, 284 (18), 12091-8. doi:10.1074/jbc.M809112200 Peer reviewed |
 | Caldwell, J. C., Contractor, H., Petkar, S., Ali, R., Clarke, B., Garratt, C. J., Neyses, L., & Mamas, M. A. (2009). Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 11 (10), 1295-300. doi:10.1093/europace/eup201 Peer Reviewed verified by ORBi |
 | Jazbutyte, V., Kehl, F., Neyses, L., & Pelzer, T. (2009). Estrogen receptor alpha interacts with 17beta-hydroxysteroid dehydrogenase type 10 in mitochondria. Biochemical and Biophysical Research Communications, 384 (4), 450-4. doi:10.1016/j.bbrc.2009.04.139 Peer reviewed |
 | Izzard, A. S., Emerson, M., Prehar, S., Neyses, L., Trainer, P., List, E. O., Kopchick, J. J., & Heagerty, A. M. (2009). The cardiovascular phenotype of a mouse model of acromegaly. Growth Hormone and IGF Research, 19 (5), 413-9. doi:10.1016/j.ghir.2008.12.006 Peer Reviewed verified by ORBi |
 | Cartwright, E. J., Oceandy, D., & Neyses, L. (2009). Physiological implications of the interaction between the plasma membrane calcium pump and nNOS. Pflügers Archiv: European Journal of Physiology, 457 (3), 665-71. doi:10.1007/s00424-008-0455-z Peer reviewed |
 | Jazbutyte, V., Arias-Loza, P. A., Hu, K., Widder, J., Govindaraj, V., von Poser-Klein, C., Bauersachs, J., Fritzemeier, K.-H., Hegele-Hartung, C., Neyses, L., Ertl, G., & Pelzer, T. (2008). Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovascular Research, 77 (4), 774-81. doi:10.1093/cvr/cvm081 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Fraser, D., & Neyses, L. (2008). Cardiovascular manifestations associated with influenza virus infection. International Journal of Cardiology, 130 (3), 304-9. doi:10.1016/j.ijcard.2008.04.044 Peer Reviewed verified by ORBi |
 | Mamas, M. A., Alonso, A., & Neyses, L. (2008). Extensive catheter-induced aortic dissection. The Canadian Journal of Cardiology, 24 (2), 9-10. doi:10.1016/s0828-282x(08)70578-6 Peer Reviewed verified by ORBi |
Caldwell, J., Mamas, M., Garratt, C., & Neyses, L. (2008). How common is asymptomatic paroxysmal atrial fibrillation in chronic heart failure? Scandinavian Cardiovascular Journal, 42 (6), 366; author reply 367. doi:10.1080/14017430802492372 Peer Reviewed verified by ORBi |
Dunn, W. B. A. B., Deepak, S. M., Buch, M. H., McDowell, G., Spasic, I., Ellis, D. I., Brooks, N., Kell, D. B., & Neyses, L. (2007). Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics, 3 (4), 413-426. doi:10.1007/s11306-007-0063-5 Peer reviewed |
Neyses, L., & Buch, M. (2007). Mechanisms of disease: An introduction to clinical sciences. In H. Tomlinson, A. Heagerty, A. Weetman, ... R. Malik (Eds.), Heart Failure (pp. 178-90). United Kingdom: Cambridge University Press. Peer reviewed |
Neyses, L., & Neyes, L. (2007). A change of scene: Ludwig Neyses, MD. Interview by Mark Nicholls. Circulation, 116 (3), 13-5. doi:10.1161/CIRCULATIONAHA.107.185651 |
 | Burkard, N., Rokita, A. G., Kaufmann, S. G., Hallhuber, M., Wu, R., Hu, K., Hofmann, U., Bonz, A., Frantz, S., Cartwright, E. J., Neyses, L., Maier, L. S., Maier, S. K. G., Renne, T., Schuh, K., & Ritter, O. (2007). Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circulation Research, 100 (3), 32-44. doi:10.1161/01.RES.0000259042.04576.6a Peer Reviewed verified by ORBi |
 | Oceandy, D., Stanley, P. J., Cartwright, E. J., & Neyses, L. (2007). The regulatory function of plasma-membrane Ca(2+)-ATPase (PMCA) in the heart. Biochemical Society transactions, 35 (Pt 5), 927-30. doi:10.1042/BST0350927 Peer reviewed |
 | Arias-Loza, P.-A., Hu, K., Dienesch, C., Mehlich, A. M., Konig, S., Jazbutyte, V., Neyses, L., Hegele-Hartung, C., Heinrich Fritzemeier, K., & Pelzer, T. (2007). Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodeling in aldosterone salt-treated rats. Hypertension, 50 (2), 432-8. doi:10.1161/HYPERTENSIONAHA.106.084798 Peer Reviewed verified by ORBi |
 | Oceandy, D., Cartwright, E. J., Emerson, M., Prehar, S., Baudoin, F. M., Zi, M., Alatwi, N., Venetucci, L., Schuh, K., Williams, J. C., Armesilla, A. L., & Neyses, L. (2007). Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation, 115 (4), 483-92. doi:10.1161/CIRCULATIONAHA.106.643791 Peer Reviewed verified by ORBi |
 | Holton, M., Yang, D., Wang, W., Mohamed, T. M. A., Neyses, L., & Armesilla, A. L. (2007). The interaction between endogenous calcineurin and the plasma membrane calcium-dependent ATPase is isoform specific in breast cancer cells. FEBS Letters, 581 (21), 4115-9. doi:10.1016/j.febslet.2007.07.054 Peer Reviewed verified by ORBi |
 | Oceandy, D., Yusoff, R., Baudoin, F. M., Neyses, L., & Ray, S. G. (2007). Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodelling in mitral valve prolapse patients. European journal of heart failure, 9 (10), 1010-7. doi:10.1016/j.ejheart.2007.07.005 Peer reviewed |
 | Cartwright, E. J., Oceandy, D., & Neyses, L. (2007). Plasma membrane calcium ATPase and its relationship to nitric oxide signaling in the heart. Annals of the New York Academy of Sciences, 1099, 247-53. doi:10.1196/annals.1387.007 Peer reviewed |
 | Oceandy, D., Mamas, M. A., & Neyses, L. (2007). Targeting the sarcolemmal calcium pump: a potential novel strategy for the treatment of cardiovascular disease. Cardiovascular and Hematological Agents in Medicinal Chemistry, 5 (4), 300-4. doi:10.2174/187152507782109890 Peer Reviewed verified by ORBi |
Oceandy, D., Buch, M. H., Cartwright, E. J., & Neyses, L. (2006). The emergence of plasma membrane calcium pump as a novel therapeutic target for heart disease. Mini Reviews in Medicinal Chemistry, 6 (5), 583-8. doi:10.2174/138955706776876177 Peer Reviewed verified by ORBi |
Gupta, S., & Neyses, L. (2006). Current thinking regarding the use of diuretics in heart failure. Heart Failure Monitor, 5 (2), 50-3. Peer Reviewed verified by ORBi |
Neyses, L. (2006). [Cardiology in Great Britain]. Deutsche medizinische Wochenschrift (1946), 131 (24), 1409-11. doi:10.1055/s-2006-946588 Peer reviewed |
 | Hallhuber, M., Burkard, N., Wu, R., Buch, M. H., Engelhardt, S., Hein, L., Neyses, L., Schuh, K., & Ritter, O. (2006). Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy. Circulation Research, 99 (6), 626-35. doi:10.1161/01.RES.0000243208.59795.d8 Peer Reviewed verified by ORBi |
 | Guo, C., Willem, M., Werner, A., Raivich, G., Emerson, M., Neyses, L., & Mayer, U. (2006). Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Human molecular genetics, 15 (6), 989-98. doi:10.1093/hmg/ddl018 Peer reviewed |
 | Williams, J. C., Armesilla, A. L., Mohamed, T. M. A., Hagarty, C. L., McIntyre, F. H., Schomburg, S., Zaki, A. O., Oceandy, D., Cartwright, E. J., Buch, M. H., Emerson, M., & Neyses, L. (2006). The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. The Journal of biological chemistry, 281 (33), 23341-8. doi:10.1074/jbc.M513341200 Peer reviewed |
 | Arias-Loza, P. A., Hu, K., Schafer, A., Bauersachs, J., Quaschning, T., Galle, J., Jazbutyte, V., Neyses, L., Ertl, G., Fritzemeier, K.-H., Hegele-Hartung, C., & Pelzer, T. (2006). Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats. Hypertension, 48 (5), 994-1001. doi:10.1161/01.HYP.0000242482.57186.e8 Peer Reviewed verified by ORBi |
 | Jazbutyte, V., Hu, K., Kruchten, P., Bey, E., Maier, S. K. G., Fritzemeier, K.-H., Prelle, K., Hegele-Hartung, C., Hartmann, R. W., Neyses, L., Ertl, G., & Pelzer, T. (2006). Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats. Hypertension, 48 (4), 579-86. doi:10.1161/01.HYP.0000240053.48517.c7 Peer Reviewed verified by ORBi |
 | Arias-Loza, P. A., Jazbutyte, V., Fritzemeier, K. H., Hegele-Hartung, C., Neyses, L., Ertl, G., & Pelzer, T. (2006). Functional effects and molecular mechanisms of subtype-selective ERalpha and ERbeta agonists in the cardiovascular system. Ernst Schering Foundation symposium proceedings, (1), 87-106. doi:10.1007/2789_2006_018 Peer reviewed |
 | Withers, S., Cartwright, E. J., & Neyses, L. (2006). Sperm phenotype of mice carrying a gene deletion for the plasma membrane calcium/calmodulin dependent ATPase 4. Molecular and Cellular Endocrinology, 250 (1-2), 93-7. doi:10.1016/j.mce.2005.12.028 Peer reviewed |
 | Bauer, S., Maier, S. K. G., Neyses, L., & Maass, A. H. (2005). Optimization of gene transfer into neonatal rat cardiomyocytes and unmasking of cytomegalovirus promoter silencing. DNA and cell biology, 24 (6), 381-7. doi:10.1089/dna.2005.24.381 Peer reviewed |
| Buch, M. H., Pickard, A., Rodriguez, A., Gillies, S., Maass, A. H., Emerson, M., Cartwright, E. J., Williams, J. C., Oceandy, D., Redondo, J. M., Neyses, L., & Armesilla, A. L. (2005). The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. The Journal of biological chemistry, 280 (33), 29479-87. doi:10.1074/jbc.M501326200 Peer reviewed |
 | Pelzer, T., Jazbutyte, V., Hu, K., Segerer, S., Nahrendorf, M., Nordbeck, P., Bonz, A. W., Muck, J., Fritzemeier, K.-H., Hegele-Hartung, C., Ertl, G., & Neyses, L. (2005). The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovascular Research, 67 (4), 604-12. doi:10.1016/j.cardiores.2005.04.035 Peer Reviewed verified by ORBi |
 | Pelzer, T., Loza, P.-A. A., Hu, K., Bayer, B., Dienesch, C., Calvillo, L., Couse, J. F., Korach, K. S., Neyses, L., & Ertl, G. (2005). Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction. Circulation, 111 (12), 1492-8. doi:10.1161/01.CIR.0000159262.18512.46 Peer Reviewed verified by ORBi |
 | Burkard, N., Becher, J., Heindl, C., Neyses, L., Schuh, K., & Ritter, O. (2005). Targeted proteolysis sustains calcineurin activation. Circulation, 111 (8), 1045-53. doi:10.1161/01.CIR.0000156458.80515.F7 Peer Reviewed verified by ORBi |
 | Pelzer, T., Jazbutyte, V., Arias-Loza, P. A., Segerer, S., Lichtenwald, M., Law, M. P., Schafers, M., Ertl, G., & Neyses, L. (2005). Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats. Biochemical and biophysical research communications, 329 (2), 726-32. doi:10.1016/j.bbrc.2005.02.029 Peer reviewed |
 | Gupta, S., & Neyses, L. (2005). Diuretic usage in heart failure: a continuing conundrum in 2005. European heart journal, 26 (7), 644-9. doi:10.1093/eurheartj/ehi176 Peer reviewed |
 | Cartwright, E. J., Schuh, K., & Neyses, L. (2005). Calcium transport in cardiovascular health and disease--the sarcolemmal calcium pump enters the stage. Journal of Molecular and Cellular Cardiology, 39 (3), 403-6. doi:10.1016/j.yjmcc.2005.04.007 Peer reviewed |
 | Schuh, K., Cartwright, E. J., Jankevics, E., Bundschu, K., Liebermann, J., Williams, J. C., Armesilla, A. L., Emerson, M., Oceandy, D., Knobeloch, K.-P., & Neyses, L. (2004). Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility. The Journal of biological chemistry, 279 (27), 28220-6. doi:10.1074/jbc.M312599200 Peer reviewed |
 | Armesilla, A. L., Williams, J. C., Buch, M. H., Pickard, A., Emerson, M., Cartwright, E. J., Oceandy, D., Vos, M. D., Gillies, S., Clark, G. J., & Neyses, L. (2004). Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). The Journal of biological chemistry, 279 (30), 31318-28. doi:10.1074/jbc.M307557200 Peer reviewed |
 | Schuh, K., Quaschning, T., Knauer, S., Hu, K., Kocak, S., Roethlein, N., & Neyses, L. (2003). Regulation of vascular tone in animals overexpressing the sarcolemmal calcium pump. The Journal of biological chemistry, 278 (42), 41246-52. doi:10.1074/jbc.M307606200 Peer reviewed |
 | Schuh, K., Uldrijan, S., Gambaryan, S., Roethlein, N., & Neyses, L. (2003). Interaction of the plasma membrane Ca2+ pump 4b/CI with the Ca2+/calmodulin-dependent membrane-associated kinase CASK. The Journal of biological chemistry, 278 (11), 9778-83. doi:10.1074/jbc.M212507200 Peer reviewed |
 | Widder, J., Pelzer, T., von Poser-Klein, C., Hu, K., Jazbutyte, V., Fritzemeier, K.-H., Hegele-Hartung, C., Neyses, L., & Bauersachs, J. (2003). Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR. Hypertension, 42 (5), 991-6. doi:10.1161/01.HYP.0000098661.37637.89 Peer Reviewed verified by ORBi |
 | Ritter, O., & Neyses, L. (2003). The molecular basis of myocardial hypertrophy and heart failure. Trends in Molecular Medicine, 9 (7), 313-21. doi:10.1016/S1471-4914(03)00114-X Peer Reviewed verified by ORBi |
 | Ritter, O., Schuh, K., Brede, M., Rothlein, N., Burkard, N., Hein, L., & Neyses, L. (2003). AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway. FASEB Journal, 17 (2), 283-5. doi:10.1096/fj.02-0321fje Peer Reviewed verified by ORBi |
 | Maass, A., Langer, S. J., Oberdorf-Maass, S., Bauer, S., Neyses, L., & Leinwand, L. A. (2003). Rational promoter selection for gene transfer into cardiac cells. Journal of Molecular and Cellular Cardiology, 35 (7), 823-31. doi:10.1016/S0022-2828(03)00140-8 Peer reviewed |
Pelzer, T., de Jager, T., Muck, J., Stimpel, M., & Neyses, L. (2002). Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition. Journal of Hypertension, 20 (5), 1001-6. doi:10.1097/00004872-200205000-00036 Peer Reviewed verified by ORBi |
 | Ritter, O., Hack, S., Schuh, K., Rothlein, N., Perrot, A., Osterziel, K. J., Schulte, H. D., & Neyses, L. (2002). Calcineurin in human heart hypertrophy. Circulation, 105 (19), 2265-9. doi:10.1161/01.CIR.0000016044.19527.96 Peer Reviewed verified by ORBi |
 | Bonz, A. W., Lengenfelder, B., Strotmann, J., Held, S., Turschner, O., Harre, K., Wacker, C., Waller, C., Kochsiek, N., Meesmann, M., Neyses, L., Schanzenbacher, P., Ertl, G., & Voelker, W. (2002). Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). Journal of the American College of Cardiology, 40 (4), 662-8. doi:10.1016/S0735-1097(02)02014-4 Peer reviewed |
 | Ritter, O., Bottez, N., Burkard, N., Schulte, H. D., & Neyses, L. (2002). A molecular mechanism improving the contractile state in human myocardial hypertrophy. Experimental and Clinical Cardiology, 7 (2-3), 151-7. Peer reviewed |
 | de Jager, T., Pelzer, T., Muller-Botz, S., Imam, A., Muck, J., & Neyses, L. (2001). Mechanisms of estrogen receptor action in the myocardium. Rapid gene activation via the ERK1/2 pathway and serum response elements. The Journal of biological chemistry, 276 (30), 27873-80. doi:10.1074/jbc.M010984200 Peer reviewed |
 | Schuh, K., Uldrijan, S., Telkamp, M., Rothlein, N., & Neyses, L. (2001). The plasmamembrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. The Journal of cell biology, 155 (2), 201-5. doi:10.1083/jcb.200104131 Peer reviewed |
 | Pelzer, T., Neumann, M., de Jager, T., Jazbutyte, V., & Neyses, L. (2001). Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta. Biochemical and biophysical research communications, 286 (5), 1153-7. doi:10.1006/bbrc.2001.5519 Peer reviewed |
 | Piuhola, J., Hammes, A., Schuh, K., Neyses, L., Vuolteenaho, O., & Ruskoaho, H. (2001). Overexpression of sarcolemmal calcium pump attenuates induction of cardiac gene expression in response to ET-1. American journal of physiology. Regulatory, integrative and comparative physiology, 281 (3), 699-705. doi:10.1152/ajpregu.2001.281.3.r699 Peer reviewed |
 | Pelzer, T., Neumann, M., deJager, T., Stimpel, M., Serfling, E., Neyses, L., & Michael, S. (2000). 17beta-estradiol prevents programmed cell death in cardiac myocytes. Biochemical and biophysical research communications, 268 (1), 192-200. doi:10.1006/bbrc.2000.2073 Peer reviewed |
 | Benkwitz, C., Oberdorf-Maass, S., & Neyses, L. (1999). Combined SSCP and heteroduplex analysis of the human plasma membrane Ca(2+)-ATPase isoform 1 in patients with essential hypertension. Biochemical and biophysical research communications, 261 (2), 515-20. doi:10.1006/bbrc.1999.1064 Peer reviewed |
 | Shamim, A., Pelzer, T., Grohe, C., & Neyses, L. (1999). Induction of Egr-1 mRNA and protein by endothelin 1, angiotensin II and norepinephrine in neonatal cardiac myocytes. Molecular and Cellular Biochemistry, 195 (1-2), 11-7. doi:10.1023/A:1006887307568 Peer reviewed |
Grohe, C., Kahlert, S., Lobbert, K., Neyses, L., van Eickels, M., Stimpel, M., & Vetter, H. (1998). Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. Journal of Hypertension, 16 (3), 377-84. doi:10.1097/00004872-199816030-00015 Peer Reviewed verified by ORBi |
 | Hammes, A., Oberdorf-Maass, S., Rother, T., Nething, K., Gollnick, F., Linz, K. W., Meyer, R., Hu, K., Han, H., Gaudron, P., Ertl, G., Hoffmann, S., Ganten, U., Vetter, R., Schuh, K., Benkwitz, C., Zimmer, H. G., & Neyses, L. (1998). Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats. Circulation Research, 83 (9), 877-88. doi:10.1161/01.RES.83.9.877 Peer reviewed |
Beer, M., Tschammler, A., Wittenberg, G., Neyses, L., & Hahn, D. (1998). [Compression therapy of a ruptured spurious aneurysm]. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren, 168 (3), 291-3. doi:10.1055/s-2007-1015128 Peer reviewed |
Neyses, L., & Pelzer, T. (1997). Sex specific mechanisms of cardiovascular disease. In M. Stimpel & A. Zanchetti (Eds.), Hypertension after menopause (pp. 93-100). Berlin, Unknown/unspecified: Walter de Gruyter. Peer reviewed |
Neyses, L., Pelzer, T., Maas, A., & Kochsiek, K. (1997). Was ist bei Vorhofflimmern zu beachten? Der Bayerische Internist, (17), 24-29. Peer reviewed |
Pelzer, T., Shamim, A., Wolfges, S., Schumann, M., & Neyses, L. (1997). Modulation of cardiac hypertrophy by estrogens. In A. Zanchetti, R. B. Devereux, L. Hansson, ... S. Gorini (Eds.), Hypertension and the Heart (pp. 83-9). New York, United States: Plenum Press. doi:10.1007/978-1-4615-5385-4_9 Peer reviewed |
 | Kahlert, S., Grohe, C., Karas, R. H., Lobbert, K., Neyses, L., & Vetter, H. (1997). Effects of estrogen on skeletal myoblast growth. Biochemical and biophysical research communications, 232 (2), 373-8. doi:10.1006/bbrc.1997.6223 Peer reviewed |
 | Grohe, C., Kahlert, S., Lobbert, K., Stimpel, M., Karas, R. H., Vetter, H., & Neyses, L. (1997). Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Letters, 416 (1), 107-12. doi:10.1016/S0014-5793(97)01179-4 Peer Reviewed verified by ORBi |
 | Grohe, C., Kahlert, S., Lobbert, K., van Eickels, M., Stimpel, M., Vetter, H., & Neyses, L. (1997). Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth. British Journal of Pharmacology, 121 (7), 1350-4. doi:10.1038/sj.bjp.0701263 Peer Reviewed verified by ORBi |
 | Benkwitz, C., Kubisch, C., Kraft, K., & Neyses, L. (1997). Investigation of the Met-267 Arg exchange in isoform 1 of the human plasma membrane calcium pump in patients with essential hypertension by the amplification-created restriction site technique. Journal of Molecular Medicine, 75 (1), 62-6. doi:10.1007/s001090050088 Peer reviewed |
Neyses, L., Blaufuss, B., Kubisch, C., Wollnik, B., Maass, A., Oberdorf, S., Grohe, C., & Vetter, H. (1996). Use of antisense oligonucleotides for selective inhibition of gene expression in cardiomyocytes. In J. Grote & C. Stick (Eds.), Tissue response to hypoxia and ischemia (pp. 53-62). Stuttgart, Unknown/unspecified: Fischer Verlag. Peer reviewed |
Neyses, L., Grohe, C., & Vetter, H. (1996). Molecular Biology of oncogenes and cardiovascular hypertrophy. In K. Lindpaintner & D. Ganten (Eds.), Molecular Reviews in Cardiovascular Medicine (pp. 89-105). London, Unknown/unspecified: Chapman and Hall. Peer reviewed |
Neyses, L. (1996). Molekulare Mekchanismen der Myokardhypertrophie. In M. Ludwig & U. Winter (Eds.), Arterosklerotische Gefaessserkrankungen (pp. 25-31). Bonn, Unknown/unspecified: Kargerer Kommunikation. Peer reviewed |
Dominiak, P., Erdmann, E., Kreuzer, H., Buchwald, A. B., Motz, W., Neyses, L., & Unger, T. (1996). [Beta blockers in chronic heart failure. Clinical position on the topic]. Der Internist, 37 (12), 1274-8; discussion 1279. Peer reviewed |
 | Hammes, A., Oberdorf-Maass, S., Jenatschke, S., Pelzer, T., Maass, A., Gollnick, F., Meyer, R., Afflerbach, J., & Neyses, L. (1996). Expression of the plasma membrane Ca2+-ATPase in myogenic cells. The Journal of biological chemistry, 271 (48), 30816-22. doi:10.1074/jbc.271.48.30816 Peer reviewed |
Pelzer, T., Shamim, A., & Neyses, L. (1996). Estrogen effects in the heart. Molecular and Cellular Biochemistry, 160-161, 307-13. doi:10.1007/BF00240064 Peer reviewed |
Neyses, L., & Pelzer, T. (1995). The biological cascade leading to cardiac hypertrophy. European heart journal, 16 Suppl N, 8-11. doi:10.1093/eurheartj/16.suppl_N.8 Peer reviewed |
Neyses, L. (1995). Calcium transport systems in pressure overload cardiomyopathy. In M. Timio, V. Wizemann, ... S. Venanzi (Eds.), Cardionephrology (pp. 327-330). Editorial Bios. Peer reviewed |
Neyses, L., & Pelzer, T. (1995). [Molecular adaptation of the heart to hypertension]. Zeitschrift fur Kardiologie, 84 Suppl 4, 71-6. Peer reviewed |
Maass, A., Grohe, C., Kubisch, C., Wollnik, B., Vetter, H., & Neyses, L. (1995). Hormonal induction of an immediate-early gene response in myogenic cell lines--a paradigm for heart growth. European heart journal, 16 Suppl C, 12-4. doi:10.1093/eurheartj/16.suppl_C.12 Peer reviewed |
Grohe, C., Nouskas, J., Vetter, H., & Neyses, L. (1994). Effects of nisoldipine on endothelin-1- and angiotensin II-induced immediate/early gene expression and protein synthesis in adult rat ventricular cardiomyocytes. Journal of cardiovascular pharmacology, 24 (1), 13-6. doi:10.1097/00005344-199407000-00003 Peer reviewed |
Maass, A., Grohe, C., Oberdorf, S., Sukhatme, V. P., Vetter, H., & Neyses, L. (1994). Mitogenic signals control translation of the early growth response gene-1 in myogenic cells. Biochemical and biophysical research communications, 202 (3), 1337-46. doi:10.1006/bbrc.1994.2077 Peer reviewed |
 | Hammes, A., Oberdorf, S., Strehler, E. E., Stauffer, T., Carafoli, E., Vetter, H., & Neyses, L. (1994). Differentiation-specific isoform mRNA expression of the calmodulin-dependent plasma membrane Ca(2+)-ATPase. FASEB Journal, 8 (6), 428-35. doi:10.1096/fasebj.8.6.8168693 Peer reviewed |
Wollnik, B., Kubisch, C., Maass, A., Vetter, H., & Neyses, L. (1993). Hyperosmotic stress induces immediate-early gene expression in ventricular adult cardiomyocytes. Biochemical and biophysical research communications, 194 (2), 642-6. doi:10.1006/bbrc.1993.1869 Peer reviewed |
Neyses, L., Nouskas, J., Luyken, J., Fronhoffs, S., Oberdorf, S., Pfeifer, U., Williams, R. S., Sukhatme, V. P., & Vetter, H. (1993). Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. Journal of Hypertension, 11 (9), 927-34. doi:10.1097/00004872-199309000-00006 Peer Reviewed verified by ORBi |
 | Bastide, B., Neyses, L., Ganten, D., Paul, M., Willecke, K., & Traub, O. (1993). Gap junction protein connexin40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions. Circulation Research, 73 (6), 1138-49. doi:10.1161/01.RES.73.6.1138 Peer reviewed |
 | Kubisch, C., Wollnik, B., Maass, A., Meyer, R., Vetter, H., & Neyses, L. (1993). Immediate-early gene induction by repetitive mechanical but not electrical activity in adult rat cardiomyocytes. FEBS Letters, 335 (1), 37-40. doi:10.1016/0014-5793(93)80434-V Peer Reviewed verified by ORBi |
Neyses, L., & Vetter, H. (1992). Molecular biology of oncogenes and cardiovascular hypertrophy. Journal of Hypertension, 10 (12), 1447-52. doi:10.1007/978-94-009-0083-7_11 Peer Reviewed verified by ORBi |
Neyses, L., Maass, A., Wollnik, B., Kubisch, C., Oberdorf, S., & Vetter, H. (1992). Die Bedeutung des "early growth response gene-1" bei der Induktion der Hypertensiven Myokardhypertrophie. In Regensburger Universitaetskolloquium: Fortschritte in der medizinischen Forschung - Hypertonie - molekulare Mechanismen/funktionelle Adaptation (pp. 56-66). Schattauer Verlag. Peer reviewed |
Neyses, L. (1992). [Potassium restriction and essential hypertension]. Deutsche medizinische Wochenschrift (1946), 117 (35), 1341. Peer reviewed |
 | Volkenandt, M., Koch, O., Fanin, R., Banerjee, D., Seger, A., Vogel, J., Bierhoff, E., Heidl, G., Neyses, L., & Bertino, J. R. (1992). Sequence analysis of polymerase chain reaction amplified t(14;18) chromosomal breakpoints in formalin fixed, paraffin wax embedded follicular lymphoma. Journal of clinical pathology, 45 (3), 210-2. doi:10.1136/jcp.45.3.210 Peer reviewed |
 | Sachinidis, A., Weisser, P., Ko, Y., Schulte, K., Meyer zu Brickwedde, K., Neyses, L., & Vetter, H. (1992). Angiotensin II induces formation of the early growth response gene-1 protein in rat vascular smooth muscle cells. FEBS Letters, 313 (2), 109-12. doi:10.1016/0014-5793(92)81423-J Peer Reviewed verified by ORBi |
Neyses, L., Nouskas, J., & Vetter, H. (1991). Inhibition of endothelin-1 induced myocardial protein synthesis by an antisense oligonucleotide against the early growth response gene-1. Biochemical and biophysical research communications, 181 (1), 22-7. doi:10.1016/S0006-291X(05)81376-2 Peer reviewed |
Neyses, L., Molls, M., Pelzer, T., Oberdorf, S., & Vetter, H. (1991). Isolierte Kardiomyozyten - ein Modell zur Aufklaerung der Pathophysiologie der hypertensiven Herzkrankheit - physiologische und erste molekularbiologische Ergebnisse. In D. Ganten (Ed.), Herz-Kreislaufregulation, Organprotektion und Organschaden (pp. 23-31). Springer. Peer reviewed |
Neyses, L. (1991). Kalium-Restriktion und essentielle Hypertonie. Deutsche Medizinische Wochenschrift (1946), (116), 2417-2248. Peer reviewed |
Neyses, L., & Vetter, H. (1990). [Hypertensive heart disease. Pathophysiological foundation, diagnosis and therapy]. Deutsche medizinische Wochenschrift (1946), 115 (39), 1480-6. doi:10.1055/s-2008-1065182 Peer reviewed |
Neyses, L., & Vetter, H. (1990). [Disturbed endothelium-dependent blood vessel relaxation in essential hypertension]. Deutsche medizinische Wochenschrift (1946), 115 (51-52), 1981. Peer reviewed |
Neyses, L., & Vetter, H. (1990). Hypertensive Herzkrankheit - pathophysiologische Grundlaten, Diagnostik und Therapie. Deutsche Medizinische Wochenschrift (1946), (39), 1480-1486. Peer reviewed |
Neyses, L., & Vetter, H. (1990). Isolated myocardial cells: a new tool for the investigation of hypertensive heart disease. Journal of Hypertension. Supplement), 8 (4), 99-102. Peer Reviewed verified by ORBi |
Neyses, L., & Vetter, H. (1989). Action of atrial natriuretic peptide and angiotensin II on the myocardium: studies in isolated rat ventricular cardiomyocytes. Biochemical and biophysical research communications, 163 (3), 1435-43. doi:10.1016/0006-291X(89)91139-X Peer reviewed |
Neyses, L., Nitsch, J., Tuttenberg, H. P., Korus, H. C., & Luderitz, B. (1989). [Increased atrial natriuretic peptide in essential hypertension--relation to right atrial pressure behavior]. Klinische Wochenschrift, 67 (15), 756-61. doi:10.1007/BF01745345 Peer Reviewed verified by ORBi |
Neyses, L., & Vetter, H. (1989). Impaired relaxation of the hypertrophied myocardium is potentiated by angiotensin II. Journal of Hypertension. Supplement), 7 (6), 104-5. doi:10.1097/00004872-198900076-00048 Peer Reviewed verified by ORBi |
Neyses, L., Biegel, H., Heinrichs, S., Nitsch, J., & Luderitz, B. (1988). [Diagnostic and prognostic value of plasma ANP determination after myocardial infarction]. Zeitschrift fur Kardiologie, 77 Suppl 2, 51-4. Peer reviewed |
Neyses, L., Nitsch, J., Biegel, T., Heinrichs, S., Nissen, H. D., & Luderitz, B. (1988). [Elevated levels of atrial natriuretic peptide and plasma catecholamines in arterial hypertension--indications for an interaction]. Zeitschrift fur Kardiologie, 77 (7), 407-12. Peer reviewed |
Nitsch, J., Kohler, U., Neyses, L., & Luderitz, B. (1988). [Concentrations of amiodarone and flecainide in plasma and saliva--indications for the active transport of flecainide]. Zeitschrift fur Kardiologie, 77 (2), 99-102. Peer reviewed |
Neyses, L., Stimpel, M., Locher, R., & Luederitz, B. (1988). Oxygenated sterols and intracellular calcium dynamics - comparison with cholesterol and clinical application. In J. Beck & A. Crastes de Paulet (Eds.), Biological activities of oxygenated sterols (pp. 101-106). Paris, Unknown/unspecified: INSERM Ed. Peer reviewed |
Neyses, L., Biegel, T., Heinrichs, S., Nitsch, J., & Luederitz, B. (1988). Diagnostische und prognostische Bedeutung der Plasma-ANP-Messung nach Myokardinfarkt. In Plasmabestimmung des atrialen natriuretischen Peptids (pp. 51-54). Darmstadt, Unknown/unspecified: Steinkopff Verlag. Peer reviewed |
Neyses, L., Nitsch, J., Manz, M., & Luderitz, B. (1987). [Resuscitation of a 36-year-old patient with a short PQ time and a history of Hodgkin's disease]. Der Internist, 28 (3), 196-9. Peer reviewed |
Nitsch, J., Kohler, U., Neyses, L., & Luderitz, B. (1987). Inhibition of flecainide absorption by activated charcoal. The American journal of cardiology, 60 (8), 753. doi:10.1016/0002-9149(87)90405-X Peer reviewed |
Neyses, L., Nitsch, J., Heinrichs, S., Biegel, T., & Luederitz, B. (1987). Einfluss von oraler Volumenbelastung, Herzfrequenz und Reserpin auf die Sekretion von atrialem natriuretischen Peptid beim Menschen. In V. Kreye & W. Bussmann (Eds.), Atriales natriurestisches Peptid und das kardiovaskulaere System (pp. 131-138). Darmstadt, Unknown/unspecified: Steinkopff-Verlag. Peer reviewed |
Nitsch, J., Neyses, L., Kohler, U., & Luderitz, B. (1987). [Elevated plasma flecainide concentrations in heart failure]. Deutsche medizinische Wochenschrift (1946), 112 (44), 1698-700. doi:10.1055/s-2008-1068315 Peer reviewed |
Neyses, L., Groth, H., Vetter, H., & Vetter, W. (1985). Trilostane - a new and effective drug for primary aldosteronism. In The adrenal gland and hypertension (pp. 443-448). United States: Raven Press. Peer reviewed |
 | Neyses, L., Locher, R., Stimpel, M., Streuli, R., & Vetter, W. (1985). Stereospecific modulation of the calcium channel in human erythrocytes by cholesterol and its oxidized derivatives. The Biochemical journal, 227 (1), 105-12. doi:10.1042/bj2270105 Peer reviewed |
 | Neyses, L., Reinlib, L., & Carafoli, E. (1985). Phosphorylation of the Ca2+-pumping ATPase of heart sarcolemma and erythrocyte plasma membrane by the cAMP-dependent protein kinase. The Journal of biological chemistry, 260 (18), 10283-7. Peer reviewed |
Neyses, L., Greminger, P., Bartsch, A., Luscher, T., Keller, U., Bachmann, L., Siegenthaler, W., & Vetter, W. (1985). A simple and effective method to teach patients about high blood pressure and obesity. Journal of Hypertension. Supplement), 3 (1), 27-30. Peer Reviewed verified by ORBi |
Stimpel, M., Neyses, L., Locher, R., Knorr, M., & Vetter, W. (1985). High density lipoproteins--modulators of the calcium channel? Journal of Hypertension. Supplement), 3 (3), 49-51. Peer Reviewed verified by ORBi |
Neyses, L., Dorst, K., Michaelis, J., Berres, M., Philipp, T., Distler, A., Losse, H., Vetter, H., Epstein, F. H., & Vetter, W. (1985). Compliance with salt restriction as a limiting factor in the primary prevention of hypertension. Journal of Hypertension. Supplement), 3 (1), 87-90. Peer Reviewed verified by ORBi |
Stimpel, M., & Neyses, L. (1985). The mechanism of action of calcium antagonists [DER WIRKUNGSMECHANISMUS DER KALZIUMANTAGONISTEN]. Schweizerische Rundschau für Medizin Praxis, 74 (19), 483-490. Peer Reviewed verified by ORBi |
Stimpel, M., Vetter, H., Kuffer, B., Neyses, L., Greminger, P., Groth, H., & Vetter, W. (1985). [Divisible tablets--source of error in therapeutic drug dosages]. Schweizerische Rundschau für Medizin Praxis, 74 (5), 84-6. Peer Reviewed verified by ORBi |
Stimpel, M., & Neyses, L. (1985). [Mechanism of action of calcium antagonists]. Schweizerische Rundschau für Medizin Praxis, 74 (19), 483-90. Peer Reviewed verified by ORBi |
Locher, R., Neyses, L., Stimpel, M., Kuffer, B., & Vetter, W. (1984). The cholesterol content of the human erythrocyte influences calcium influx through the channel. Biochemical and biophysical research communications, 124 (3), 822-8. doi:10.1016/0006-291X(84)91031-3 Peer reviewed |
Neyses, L., Locher, R., Wehling, M., Pech, H., Tenschert, W., & Vetter, W. (1984). Angiotensin II binding to human mononuclear cells: receptor or free fluid endocytosis? Clinical Science, 66 (5), 605-12. doi:10.1042/cs0660605 Peer reviewed |
Stimpel, M., Neyses, L., Locher, R., Groth, H., & Vetter, W. (1984). Human red blood cells--an ideal model system for the action of calcium agonists and antagonists. Journal of Hypertension. Supplement), 2 (3), 577-80. Peer Reviewed verified by ORBi |
Neyses, L., Stimpel, M., Locher, R., Streuli, R., Kuffer, B., & Vetter, W. (1984). Cholesterol and its oxidized derivatives modulate the calcium channel in human red blood cells. Journal of Hypertension. Supplement), 2 (3), 489-92. Peer Reviewed verified by ORBi |
Groth, H., Foerster, E. C., Neyses, L., Kulhmann, U., Vetter, H., & Vetter, W. (1984). [Nifedipine in hypertensive emergencies and severe hypertension]. Schweizerische Rundschau für Medizin Praxis, 73 (2), 45-9. Peer Reviewed verified by ORBi |
Wehling, M., Vetter, W., Neyses, L., Groth, H., Boerlin, H. J., Locher, R., Siegenthaler, W., & Kuhlmann, U. (1983). Altered calcium and sodium metabolism in red blood cells of hypertensive man: assessment by ion-selective electrodes. Journal of Hypertension, 1 (2), 171-6. doi:10.1097/00004872-198308000-00010 Peer Reviewed verified by ORBi |
Neyses, L., Groth, H., & Vetter, W. (1983). Acceptability in food of NaCl/KCl mixture. Lancet, 2 (8364), 1427-8. doi:10.1016/S0140-6736(83)90964-9 Peer reviewed |
Bartsch, A., Neyses, L., Greminger, P., Luscher, T., Keller, U., Bachmann, L., Siegenthaler, W., & Vetter, W. (1983). A slide program on hypertension and obesity: a simple method of patient information. Schweizerische Medizinische Wochenschrift, 113 (50), 1929-33. Peer Reviewed verified by ORBi |
Neyses, L. (1983). Beta-blockade in den achtziger Jahren. Swiss Medical Weekly, (4), 79-84. Peer Reviewed verified by ORBi |
Greminger, P., Kuhlmann, U., Vetter, W., Gruntzig, A., Schneider, E., Pouliadis, G., Wehling, M., Neyses, L., & Siegenthaler, W. (1982). [Long-term progress following percutaneous transluminal dilatation of renal artery stenosis]. VASA. Zeitschrift fur Gefasskrankheiten, 11 (4), 362-6. Peer reviewed |
Mussel, H. H., Ehlen, T., Schmitt, M., Kazatchkine, M. D., Neyses, L., & Dierich, M. P. (1982). Isolation and characterization of the C3b-binding entity of C3b-receptor from human erythrocytes. Immunology letters, 4 (1), 1-6. doi:10.1016/0165-2478(82)90069-4 Peer reviewed |